Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista Colombiana de Cirugía
versión impresa ISSN 2011-7582versión On-line ISSN 2619-6107
Resumen
BARRERA-LOZANO, Luis Manuel et al. Mesohepatectomy, an alternative for the management of hepatocellular carcinoma in non-cirrhotic patient: case series. rev. colomb. cir. [online]. 2022, vol.37, n.1, pp.96-105. Epub 20-Mar-2022. ISSN 2011-7582. https://doi.org/10.30944/20117582.928.
Introduction.
Surgical resection is the treatment of choice for primary and secondary neoplasms of the liver. Patients with central segment hepatocarcinoma represent a challenge, with extended hepatectomy being the most widely used technique. However, the postsurgical risk of liver failure is high since resection can compromise between 65% and 80% of liver volume. Mesohepatectomy is an alternative that allows a sufficient residual liver volume to be left. The objective of this work is to present treatment of patients with central segment hepatocarcinoma.
Clinical cases.
Three non-cirrhotic patients are presented, with hepatocarcinoma in segments 4, 5 and 8, who were treated at the San Vicente Fundación Hospital in Medellín and Rionegro, between 2018 and 2020.
Results.
Mesohepatectomy was performed by selective ligation of the pedicles of segment 4 and the right anterior sector. An ultrasonic aspirator and endostapler were used for liver transection. The duration of the Pringle maneuver ranged from 16 to 43 minutes. The average bleeding was 1000 cc. Only one patient had type B bile leakage. There was no 30-day mortality.
Conclusions.
Mesohepatectomy is a safe alternative for patients with tumors in the central segments, which reduces the risk of liver failure after resection.
Palabras clave : hepatocarcinoma; hepatectomy; central; extended; liver failure; postoperative; hepatic cirrhosis.